DKCM
OBIO icon

Davidson Kempner Capital Management’s Orchestra BioMed OBIO Stock Holding History

Davidson Kempner Capital Management’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-245,213
Closed -$2.45M – 412
2022
Q4 		$2.45M Hold
245,213
– – 0.05% 247
2022
Q3 		$2.43M Sell
245,213
-230,000
-48% -$2.28M 0.05% 290
2022
Q2 		$4.73M Sell
475,213
-500,000
-51% -$4.97M 0.09% 213
2022
Q1 		$9.66M Hold
975,213
– – 0.14% 133
2021
Q4 		$9.75M Hold
975,213
– – 0.15% 117
2021
Q3 		$9.6M Buy
975,213
+50,000
+5% +$494K 0.14% 126
2021
Q2 		$9.44M Buy
925,213
+300,487
+48% +$3.11M 0.07% 160
2021
Q1 		$6.96M Buy
624,726
+196,871
+46% +$2.4M 0.07% 172
2020
Q4 		$5.39M Sell
427,855
-25,000
-6% -$285K 0.06% 175
2020
Q3 		$4.98M Buy
+452,855
New +$5.09M 0.07% 171

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
SFG
SVB Financial Group Dallas, Texas $434K AUM 277.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return